These compounds have extensively been used as
pharmaceuticals,9 agrochemicals,10 and intermediates8a,11
forthepreparation of acyclicand cycliccompoundshaving
two sulfur-containing functional groups on adjacent car-
bon atoms.12 There are several publications illustrating
intramolecular or intermolecular oxygen sulfur exchange.13
In our ongoing efforts4 to develop dually active vaginal
microbicides, we attempted to hybridize a spermicidal
pharmacophore dithiocarbamate4,14 and microbicidal moiety
thiocarbonates.15
pursue the rearrangement chemistry illustrated in scheme 1.
In this paper, a new route toward the synthesis of S-(2-
thioxo-1,3-dithiolan-4-yl)methyl dialkylcarbamothioates (3)
and S-thiiran-2-ylmethyl-dialkylcarbamothioate (5) utilizing
5-(chloromethyl)-1,3-oxathiolane-2-thione (1)18 is reported
where 1 has been used for the first time as the starting
material.
To explore the versality of the reaction (Scheme 1), the
reaction of 1 with various sodium dialkylcarbamodithio-
ates (2) was studied. The reaction of sodium 4-methylpi-
perazine-1-carbodithioate (2a) with 1 was chosen as model
reaction for optimization (Table 1). This model reaction
was carried out in different solvents at room temperature
as well as at reflux temperature. The duration of reaction
and the isolated yields were observed. There was no
progress in the reactions after hours at room temperature,
while at reflux the reactions were completed at different
time periods. Significant rate enhancement was observed
in water compared to organic solvents (Table 1). This
acceleration is probably due to factors such as hydropho-
bic effect,19 enhanced hydrogen bonding in the transition
state,20 etc.
Scheme 1. Reactions of 5-(chloromethyl)-1,3-oxathiolane-2-
thione (1) with (2a) and (4a)
In a logical extension of our initial study, it was envi-
saged that the reaction of sodium 4-methylpiperazine-1-
carbodithioate (2a) with 5-(chloromethyl)-1,3-oxathio-
lane-2-thione (1) would give rise to S-(2-thioxo-1,3-ox-
athiolan-5-yl)methyl 4-methylpiperazine-1-carbodithioate
(6, Scheme 1). However, contrary to our expectation, the
desired compound 6 was not obtained, and surprisingly,
the major product was found to be S-(2-thioxo-1,3-dithio-
lan-4-yl)methyl 4-methylpiperazine-1-carbothioate (3b),
isolated in 96% yield. The structural elucidation of com-
pound 3b revealed that oxygenꢀsulfur exchange between
dithiocarbamate (2a) and cyclic dithiocarbonate (1) had
occurred. Moreover, to study the course of the reaction,
efforts were made to replace the chlorine atom of 1 with N-
methylpiperazine (4a). The results obtained were again
unusual as S-thiiran-2-ylmethyl 4-methylpiperazine-1-car-
bothioate (5b) was formed instead of 7 (Scheme 1). How-
ever, it is interesting to note that an alkyl (other than
chloromethyl)-substituted 1,3-oxathiolane-2-thione re-
acted with amines to undergo ring-opening reaction and
to obtain thiourethanes having thiol moiety.16 There seems
to be no direct precedent for this rearrangement, although
there is some resemblance17 provided the motivation to
Table 1. Reaction of 1 with Sodium 4-Methylpiperazine-1-
Carbodithioate (2a)a
entry
solventb
time (h)
yieldc (%) of 3b
1
2
3
4
5
6
7
methanol
THF
2
8
70
67
62
72
80
77
96
ethyl acetate
acetonitrile
chloroform
DCM
9
6.5
7
10
1
water
a 1.2 equiv. b Reaction carried out at reflux temperatures. c Isolated
yields.
The structure of 3b was elucidated by IR, 1H NMR, and
13C NMR spectra. In the IR spectrum, a strong peak was
observed at 1650 cmꢀ1 for CdO, while in the 13C NMR
spectrum, there was no chemical shift for Nꢀ(CdS)ꢀS (δ
192ꢀ195)4 and Oꢀ(CdS)ꢀS (δ 210)16 while there were
chemical shifts at δ 165.2 [Nꢀ(CdO)ꢀS] and δ 226.6
[Sꢀ(CdS)ꢀS]21 that justified the presence of thiocarba-
mate and trithiocarbonate groups in 3b. Thus, the unusual
product was presumably formed via oxygen sulfur swap
over between 1 and 2a. In addition, the aliquots obtained
during the reaction exhibited m/z 185 (Mþ þ 1) in the
ESIꢀMS spectrum, which revealed the intermittent for-
mation of intermediate IV (Scheme 2).
(12) Corey, E. J.; Mitra, R. B. J. Am. Chem. Soc. 1962, 84, 2938.
(13) (a) Burns, M.; Lloyd-Jones, G. C.; Moseley, J. D.; Renny, J. S. J.
Org. Chem. 2010, 75, 6347–6353. (b) Kalicki, P.; Karchier, M.; Michalak,
K.; Wicha, J. J. Org. Chem. 2010, 75, 5388–5391. (c) Doyle, W. C., Jr. US
Patent 3 728 371, 1973; Chem. Abstr. 1973, 79, 5246. (d) Rollin, P.
Tetrahedron Lett. 1986, 27, 4169.
(18) Halimehjani, A. Z.; Ebrahimi, F.; Azizi, N.; Saidi, M. R. J.
Heterocycl. Chem. 2009, 46, 347–350.
(14) Tripathi, R. P.; Khan, A. R.; Setty, B. S.; Bhaduri, A. P. Acta
Pharm. 1996, 46, 169–176.
(19) (a) Breslow, R. Acc. Chem. Res. 1991, 24, 159–164. (b) Otto, S.;
Engberts, J. B. F. N. Org. Biomol. Chem. 2003, 1, 2809–2820.
(20) Chandrasekhar, J.; Shariffskul, S.; Jorgensen, W. L. J. Phys.
Chem. B 2002, 106, 8078–8085.
(21) Clegg, W.; Harrington, R. W.; North, M.; Villuendas, P. J. Org.
Chem. 2010, 75, 6201–6207.
(15) (a) Overberger, C. G.; Drucker, A. J. Org. Chem. 1964, 29, 360.
(b) Yasuda, N.; Yatami, T.; Ohnuki, T.; Okutsu, M. J. Heterocycl.
Chem. 1984, 21, 1845.
(16) (a) Choi, W.; Sanda, F.; Endo, T. J. Polym. Sci., Part A: Polym.
Chem. 1998, 36, 1189–1195. (b) Choi, W.; Nakajima, M.; Sanda, F.;
Endo, T. Macromol. Chem. Phys. 1998, 199, 1909–1915.
(17) Kiran Kumar, S. T. V. S; Sharma, V. L.; Dwivedi, A. K. J.
Heterocycl. Chem. 2006, 43, 001–005.
(22) Guseinova, A. T.; Rzaeva, I. A.; Alieva, K. I.; Aliev, I. A.;
Allakhverdiev, M. A. Russ. J. Appl. Chem. 2009, 82, 2151–2155.
Org. Lett., Vol. 13, No. 9, 2011
2331